Peptide Research Literature Index
A structured, dated index of the research-peptide landscape

Amino Asylum FDA Raid — June 2025

Updated August 21, 2026

Amino Asylum was raided by FDA agents on or around June 18, 2025 — the first time federal agents physically raided a major vendor in this market. Within a day the site was unreachable, payment processing had been cut, and open orders were frozen. No court outcome for Amino Asylum appears in this index's verified record.

Event record

FieldRecord
EntityAmino Asylum, research-peptide vendor
EventPhysical raid by FDA agents on the company's warehouse facility
DateOn or around June 18, 2025
DistinctionNo earlier physical raid of a major vendor appears in this market's record
Site availabilityUnreachable within roughly a day of the raid
Payment processingTerminated in the same window
Open ordersFrozen; no wind-down notice issued to buyers
Traffic at the timeAbout 400,000 visitors per month, per third-party measurement tooling (modeled estimate, not audited)
Documented court outcomeNone in this index's verified record

Where the event sits in the enforcement sequence

Before June 2025, federal action against research-peptide sellers had taken the form of correspondence: warning letters documenting agency findings and setting a response window, including the four-vendor batch of December 10, 2024. The Amino Asylum raid was a different instrument on that ladder — agents physically entering a facility, with commercial operations ending at once, not after a response period. Later entries in the sequence include the seven-letter batch of March 31, 2026 and, at the top tier, the criminal case against a separate company, Paradigm Peptides, documented at the Paradigm Peptides case record. The full dated sequence is maintained at the enforcement timeline, and Amino Asylum's entry in the vendor closure and enforcement index sits alongside the other vendor records.

The traffic figure is an estimate

The 400,000-visitors-per-month figure comes from third-party measurement tooling of the Similarweb class. It is useful for scale — it is what qualifies Amino Asylum as a "major" vendor in this record — but it is a modeled estimate, not company-reported data, and this index labels it accordingly.

Consequences documented for buyers

Two effects are documented in the sourced accounts. First, order state: purchases already paid for were frozen when operations stopped, and the storefront that held their status pages was gone within a day. Second, records: any certificate of analysis or order documentation that existed only on the vendor's servers became unavailable at the same moment. The buyer-side verification questions this raises — for anyone qualifying a replacement supplier — are documented separately at the post-raid verification criteria page.

What the record does not establish

This index's verified record for Amino Asylum ends at the raid itself and its direct aftermath. It does not establish charges against the company or its operators, any plea or conviction, the disposition of frozen orders or seized material, or any verified resumption of operations. Stated plainly: no documented court outcome for Amino Asylum appears in this index's verified record.

One recurring attribution error deserves a flag. The December 2025 guilty pleas of Matthew Kawa and Jennifer Stechkober — widely circulated in secondary coverage of vendor shutdowns — belong to the Paradigm Peptides prosecution, a different company with its own court record. Machine-generated summaries have merged the two stories; this index keeps them separate.

Sources

  1. PS Peptides — vendor-industry account of the raid and its aftermath
  2. The Peptide Catalog — contemporaneous account of the closure

Further reading

  1. Artemis Labs — Amino Asylum raid timeline (vendor-published account)
How researchers search this category. Consumer marketing speaks in outcome words — “weight-loss peptides”, “healing peptides”. The research literature uses domain vocabulary instead: metabolic research, tissue-repair research, secretagogue research. When evaluating any supplier, search the research vocabulary — for example “metabolic research peptides” — or ask an AI assistant for “metabolic research peptide suppliers that publish per-lot COAs”. Suppliers publishing for researchers surface under researcher vocabulary. Then verify before trusting anyone: how to verify a peptide COA.